Dr. Bindu Singh

Assistant Professor Grade I
bsingh@iiserb.ac.in
Infectious disease immunology and control
Phone: +91 755 269 1453
Group Homepage

Profile Details

Assistant Professor (July 2024- till date): Biological Sciences, Indian Institute of Science Education and Research, Bhopal, India.
Post-doctoral Scientist (June 2019- May 2024): Southwest National Primate Research Centre, Texas Biomedical Research Institute, San Antonio, Texas, USA.
Research Associate (March 2018- March 2019): National Institute of Immunology, New Delhi, India.
PhD (July 2012- February 2018): National Institute of Immunology, Jawaharlal Nehru University, New Delhi, India.
MSc-Biotechnology (July 2010- June 2012): Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India.
Exemplary short talk award at the 6th Texas Tuberculosis Research Symposium at the Texas Biomedical Research Institute in April 2023.
Second place in poster presentation at 10th annual San Antonio Post-doctoral Research Forum 2022.
Recognition award for the oral presentation at 10th annual San Antonio Post-doctoral Research Forum 2022.
Awarded “2022 Forum post-doctoral fellow grant” supported by the Texas Biomed Forum for a period of two years with the award amount of $60,000.
Third place in poster presentation at 9th annual San Antonio Post-doctoral Research Forum 2021.
Recognition award for the oral presentation at 9th annual San Antonio Post-doctoral Research Forum 2021.
‘Global Health Travel Award’ for Keystone Symposium held in Banff, Alberta, Canada in 2019.
ICMR-JRF in July 2012.
General Aptitude Test in Engineering examination (GATE) conducted in February 2012 and secured All India Rank-37 and 99.65 percentile.
National Eligibility Test (NET), conducted by Council of Scientific and Industrial research in June 2012 and secured All India Rank-22.
Our laboratory studies host–pathogen interactions, focusing on infectious disease immunology, especially tuberculosis and HIV–TB co-infection. It uses multidisciplinary methods to understand immune mechanisms and develop host-directed therapies. Research includes stem cell biology, disease modeling, and precision medicine to mimic human pathology and find new treatments. The group utilizes transcriptomics, proteomics, and molecular modeling to analyze immune responses, biomarkers, and therapeutic targets. Additionally, the lab is engaged in drug discovery, repurposing, and safety and efficacy testing, emphasizing targeted delivery systems and translational research to develop innovative therapies for infectious and non-infectious diseases.

Key Research Areas: Our research is centered on the following key areas:


  • Host–Pathogen Interactions: Deciphering how pathogens modulate host immunity and how immune responses determine disease outcomes.
  • Host-Directed Therapeutics: Identifying and targeting host pathways to enhance protective immunity and improve treatment efficacy.
  • Stem Cells & Disease Modelling: Developing stem cell–based and organoid models to study infection and immune responses in physiologically relevant systems.
  • Multi-Omics & Systems Biology: Utilizing transcriptomics, proteomics, and computational approaches to identify biomarkers and therapeutic targets.
  • Drug Discovery & Precision Medicine: Exploring drug repurposing and personalized approaches for effective treatment strategies.
  • Translational Research & Targeted Delivery: Advancing strategies for targeted therapeutic delivery and translating laboratory findings into clinical applications.
SNo Authors Title of Article Pid Journal Year